megestrol has been researched along with medroxyprogesterone acetate in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (40.48) | 18.7374 |
| 1990's | 16 (38.10) | 18.2507 |
| 2000's | 5 (11.90) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, L; Hart, BL | 1 |
| Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
| Labrie, C; Labrie, F; Pelletier, G; Simard, J; Zhao, HF | 1 |
| Sleijfer, DT; Tjabbes, T; van der Ploeg, E; van Veelen, H; Willemse, PH | 1 |
| Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Lundgren, S; Lønning, PE | 1 |
| Okada, H; Yamamoto, T | 1 |
| Abrams, JS; Aisner, J; Parnes, H | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Begin, DJ; Labrie, F; Luthy, IA | 1 |
| Kvinnsland, S; Lundgren, S; Utaaker, E | 1 |
| Carpenter, JT | 1 |
| Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D | 1 |
| Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E | 1 |
| Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE | 1 |
| Becher, R; Miller, AA; Schmidt, CG | 1 |
| Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Glick, JH; Haller, DG | 1 |
| Presl, J | 1 |
| Blumenschein, GR | 1 |
| Adlercreutz, H; Hämäläinen, EK; Korpela, JT; Pulkkinen, MO | 1 |
| Kauppila, A | 1 |
| Cleary, RE; Ehrlich, CE; Young, PC | 1 |
| Hellenäs, KE; Rosén, J; Shearan, P; Törnqvist, P | 1 |
| Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
| Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS | 1 |
| Espie, M | 1 |
| Cohen, JD; Robins, HI | 1 |
| Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F | 1 |
| Delansorne, R; Paris, J; Williams, JK | 1 |
| Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V | 1 |
| Boubli, L; Carpentier-Meunier, S; Charpin, C; Dales, JP; Garcia, S; Illouz, S; Lavaut, MN; Sferlazzo, K | 1 |
| Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
| Akan, P; Dogan, E; Gol, M; Karas, C; Posaci, C; Saygili, U | 1 |
| Baldacci, C; Caruso, A; Fornari, L; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Mannella, P; Scorticati, C; Simoncini, T | 1 |
| Boesch, C; Bronner, C; Hecker, M; Jourdain, M; Schini-Kerth, VB; Zerr-Fouineau, M | 1 |
| Brockbank, E; Bryant, A; Gallagher, C; Kokka, F; Oram, D | 1 |
| Huras, H; Jach, R; Kempisty-Zdebik, E; Ludwin, A; Ludwin, I; Radon-Pokracka, M; Stangel-Wojcikiewicz, K; Wadowska-Jaszczynska, K; Zdebik, A | 1 |
| Liu, FS; Liu, JC; Yang, HC | 1 |
| Fedotcheva, TA | 1 |
8 review(s) available for megestrol and medroxyprogesterone acetate
| Article | Year |
|---|---|
[Therapy of advanced endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Uterine Neoplasms | 1990 |
Current status of high-dose progestins in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progesterone Congeners | 1990 |
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant | 1995 |
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1998 |
Hormonal therapy in advanced or recurrent endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Disease-Free Survival; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Neoplasm Staging; Progestins | 2010 |
Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review).
Topics: Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Progesterone; Progestins | 2021 |
9 trial(s) available for megestrol and medroxyprogesterone acetate
| Article | Year |
|---|---|
Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats.
Topics: Animals; Appetite; Ataxia; Behavior, Animal; Cat Diseases; Cats; Diazepam; Female; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progestins; Recurrence; Sleep; Urination Disorders; Weight Gain | 1992 |
A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Adrenal steroids as parameters of the bioavailability of MA and MPA.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1990 |
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin | 1990 |
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation | 1987 |
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Topics: Adult; Contraceptive Agents, Female; Erythromycin; Estradiol; Estrone; Ethinyl Estradiol; Feces; Female; Humans; Intestines; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Oxytetracycline; Trimethoprim | 1984 |
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate | 1995 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
Topics: Adult; Aged; C-Reactive Protein; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norpregnadienes; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2006 |
25 other study(ies) available for megestrol and medroxyprogesterone acetate
| Article | Year |
|---|---|
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.
Topics: Androgen-Binding Protein; Animals; Cyproterone; Cyproterone Acetate; DNA Probes; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Nucleic Acid Hybridization; Progesterone Congeners; Prostate; Prostatein; Rats; Rats, Inbred Strains; RNA, Messenger; Secretoglobins; Testosterone Congeners; Uteroglobin | 1990 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture.
Topics: Androgens; Animals; Cell Division; Chlormadinone Acetate; Dihydrotestosterone; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Mice; Progestins; Spironolactone; Tumor Cells, Cultured | 1988 |
Oral high-dose progestins as treatment for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies | 1989 |
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged | 1986 |
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin | 1986 |
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay | 1988 |
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1988 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
[Gestagens and the treatment of hot flushes in the postmenopausal period].
Topics: Climacteric; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1983 |
The role of progestins in the treatment of breast cancer.
Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Automated extraction of acetylgestagens from kidney fat by matrix solid phase dispersion.
Topics: Abattoirs; Adipose Tissue; Automation; Chlormadinone Acetate; Chromatography, High Pressure Liquid; Immunoenzyme Techniques; Kidney; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Radioisotope Dilution Technique; Reagent Kits, Diagnostic; Tritium | 1994 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms | 1993 |
Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys.
Topics: Acetylcholine; Animals; Coronary Artery Disease; Estrogens; Female; Macaca fascicularis; Male; Medroxyprogesterone Acetate; Megestrol; Norpregnadienes; Premenopause; Progestins; Sex Characteristics; Vasodilation; Vasodilator Agents | 1998 |
Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Cell Division; Cells, Cultured; Endometrium; Female; Glycogen; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Progesterone Congeners; Progestins; Receptors, Estradiol; Receptors, Progesterone; Time Factors | 2003 |
Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate.
Topics: Cells, Cultured; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelial Cells; Estradiol; Humans; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase; Norpregnadienes; Progesterone; Progesterone Congeners; Signal Transduction | 2006 |
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Topics: Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; GTP Cyclohydrolase; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Norpregnadienes; Platelet Aggregation; Progesterone; Progesterone Congeners; Pterins; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombosis; Time Factors | 2009 |
Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.
Topics: Adolescent; Adult; Chemoradiotherapy; Contraceptive Agents, Female; Drug Combinations; Dydrogesterone; Estradiol; Estriol; Female; Follicle Stimulating Hormone, Human; Hematologic Neoplasms; Hormone Replacement Therapy; Humans; Infertility, Female; Luteinizing Hormone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Ovarian Follicle; Primary Ovarian Insufficiency; Progesterone; Progesterone Congeners; Young Adult | 2012 |
Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol; Pregnancy | 2019 |